Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Lamborghini's focus on innovation expands beyond cars.
Walmart's new pilot program allows employees to make extra money by delivering online orders on their way home from work, reports Bloomberg.
Here are the five latest drugs or medical devices approved by the Food and Drug Administration in the past week.
Madison, Wis.-based Exact Sciences saw shares increase 12 percent after Minnetonka, Minn.-based UnitedHealthcare said it would cover the company's colon cancer screening test Cologuard, according to a Milwaukee Journal Sentinel report.
The Food and Drug Administration on Tuesday approved a new dose of Merck's HIV drug Isentress.
The Food and Drug Administration on Wednesday approved Novo Nordisk's new hemophilia treatment, Rebinyn.
Healthcare organizations face increasing regulations in the logistics, transportation and supply chain sectors, which accelerates the adoption of new technologies, according to Scott Allison, president of life sciences and healthcare sector for DHL Customer Solutions & Innovation.
Nearly half of business leaders believe their supply chains will become simpler in the near future, according to a survey from The Economist Intelligence Unit.
Amgen on May 25 filed a lawsuit against the Food and Drug Administration after the agency denied the drugmaker a six-month exclusivity period for its secondary hyperparathyroidism treatment Sensipar, reports Life Sciences Intellectual Property.
The U.S. Court of Appeals for the Eighth Circuit on May 26 ruled Fairview Health Services — a Minneapolis-based integrated health system and medical device seller — did not violate federal robocall rules, reports Blomberg BNA.